Cantor Fitzgerald began coverage on Lexicon shares.
1 report, 1 independent
Updated Oct 5
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Cantor Fitzgerald began coverage on Lexicon shares.
Who's involved
What this event is mainly aboutKeep exploring
The entities involved
-
Cantor Fitzgerald
American financial services company
-
Lexicon Pharmaceuticals
biopharmaceutical company
Nothing else this week.
Related events
- Cantor Fitzgerald affiliates organized a Special Purpose Acquisition Company (SPAC).
- Cantor Fitzgerald began coverage and issued rating, and Morgan Stanley upgraded price objective and rating for Silence Therapeutics.
- Cantor Fitzgerald hosted a healthcare conference on September 8, 2026.
- Cantor Fitzgerald restated an overweight rating for Anteris Technologies Global Corp. on October 8, 2026.
- Cantor Fitzgerald reiterated an Overweight rating for aTyr Pharma on August 20, 2025.